Business

Aeterna Zentaris to Announce Second Quarter 2014 Financial and Operating Results on August 7, 2014

QUEBEC CITY , July 31, 2014 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX...

articleCosciens Biopharma Inc.July 31, 20143/company/cosciens-biopharma-inc/news/aeterna-zentaris-to-announce-second-quarter-2014-financial-and-operating-results-on-august-7-2014
Aeterna Zentaris to Announce Second Quarter 2014 Financial and Operating Results on August 7, 2014

About this update from Cosciens Biopharma Inc.

[{"type":"text","content":"\n\nQUEBEC CITY, July 31, 2014 /CNW Telbec/ - Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZ) (the \"Company\") will announce its second quarter 2014 financial and operating results after market close on Thursday, August 7, 2014. The Company will host a conference call to discuss these results on Friday, August 8, 2014, at 8:30 a.m. eastern time. \n\nParticipants may access the live webcast via the Company's website at www.aezsinc.com in the \"Newsroom\" section, or by telephone using the following numbers: in Canada, 514-807-9895 or 647‑427‑7450, outside Canada, 888-231-8191. A replay of the webcast will also be available on the Company's website for a period of 30 days. \n\nAbout Aeterna Zentaris \n\nAeterna Zentaris is a specialty biopharmaceutical company engaged in developing novel treatments in oncology and endocrinology. The Company's pipeline encompasses compounds at various stages of development. For more information, visit www.aezsinc.com.\n\n \nSOURCE Aeterna Zentaris Inc.\n\n\n\nPaul Burroughs, Director of Communications, (418) 652-8525 ext. 406, [email protected] CNW Group 2014","length":1837,"tagName":"div"}]

More updates from Cosciens Biopharma Inc.